SCHEMBL8537614

SCHEMBL8537614

O=C(Nc1ccc(S)cc1)c1ccc(S)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.63
RAB9A P51151 3/20 0.63
MEN1 O00255 2/20 0.63
POLB P06746 2/20 0.63
KMT2A Q03164 2/20 0.63
LMNA P02545 1/20 0.63
PKM P14618 1/20 0.63
APEX1 P27695 1/20 0.63
TDP1 Q9NUW8 1/20 0.63
KDM4E B2RXH2 2/20 0.59
GAA P10253 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
PTPN1 P18031 4/20 0.57
TP53 P04637 1/20 0.57
ALOX15 P16050 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
MITF O75030 1/20 0.55
CACNA1B Q00975 1/20 0.55
APBA1 Q02410 1/20 0.55
CA1 P00915 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8826894 1.00 NPC1 (0.63) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL14531893 0.90 RAB9A (0.81) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL7396444 0.90 NPC1 (0.65) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL18058734 0.90 POLB (0.81) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL2062593 0.90 PTPN1 (0.71) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL18993404 0.86 GAA (0.81) POLBKMT2ALMNAKDM4EGAA
SCHEMBL28476840 0.85 TOP1 (0.55) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL9137810 0.84 KMT2A (0.71) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL9135236 0.84 KMT2A (0.71) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL18993451 0.81 NPC1 (0.43) NPC1RAB9AMEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240052103-A1 POLYMER AND TRIAZINE COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2024-02-15 US disclosed
EP-0708796-B1 PROCESS FOR PREPARING COMPOSITES BASED ON ORIENTED MESOGENIC THERMOSET RESINS DOW CHEMICAL CO (US) 1998-05-27 EP disclosed
US-5602211-A CURING AGENTS THE DOW CHEMICAL COMPANY (US) 1997-02-11 US disclosed
EP-0708796-A1 PROCESS FOR PREPARING COMPOSITES BASED ON ORIENTED MESOGENIC THERMOSET RESINS THE DOW CHEMICAL COMPANY (US) 1996-05-01 EP disclosed
US-5424393-A Curing into liquid crystals THE DOW CHEMICAL COMPANY (US) 1995-06-13 US disclosed
US-5414121-A Adducts of epoxy resins and active hydrogen containing compounds containing mesogenic moieties THE DOW CHEMICAL COMPANY (US) 1995-05-09 US disclosed
WO-1995002631-A1 PROCESS FOR PREPARING COMPOSITES BASED ON ORIENTED MESOGENIC THERMOSET RESINS THE DOW CHEMICAL COMPANY (US) 1995-01-26 WO disclosed
US-5342904-A Polymer modified adducts of epoxy resins and active hydrogen containing compounds containing mesogenic moieties THE DOW CHEMICAL COMPANY (US) 1994-08-30 US disclosed
US-5276184-A Curing agents for epoxy resins for thermosetting resins THE DOW CHEMICAL COMPANY (US) 1994-01-04 US disclosed
US-5248740-A Thioepoxides, liquid crystal polymers THE DOW CHEMICAL COMPANY (US) 1993-09-28 US disclosed
US-5248360-A Saturating fiber substrates with curable thermosetting resin, arranging substrates into desired configuration, curing with application of heat and pressure THE DOW CHEMICAL COMPANY (US) 1993-09-28 US disclosed
US-5235008-A Curable THE DOW CHEMICAL COMPANY (US) 1993-08-10 US disclosed
US-5182340-A Molding materials having shorter gel time with aliphatic amine curing agents THE DOW CHEMICAL COMPANY (US) 1993-01-26 US disclosed
EP-0478918-A2 Adducts of epoxy resins and active hydrogen containing compounds containing mesogenic moieties THE DOW CHEMICAL COMPANY (US) 1992-04-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240052103-A1 POLYMER AND TRIAZINE COMPOUND TERT, TERB1, MCM5 NPC1 3347/4885RAB9A 4783/4885MEN1 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.